scholarly journals A review on autoimmune diseases Myasthenia Gravis: Causes, pathogenesis, symptoms and treatment

2021 ◽  
Vol 1853 (1) ◽  
pp. 012063
Author(s):  
S A JarAllah ◽  
Z S Al-Garawi
Keyword(s):  
Autoimmune Diseases ◽  
Myasthenia Gravis

scholarly journals Overview of Dual-Acting Drug Methotrexate in Different Neurological Diseases, Autoimmune Pathologies and Cancers

2020 ◽  
Vol 21 (10) ◽  
pp. 3483 ◽  
Author(s):  
Przemysław Koźmiński ◽  
Paweł Krzysztof Halik ◽  
Raphael Chesori ◽  
Ewa Gniazdowska
Keyword(s):  
Folic Acid ◽  
Combination Therapy ◽  
Autoimmune Diseases ◽  
Myasthenia Gravis ◽  
Neurological Disorders ◽  
Chemotherapeutic Agent ◽  
Neurological Diseases ◽  
Immunosuppressive Drug ◽  
Structural Analogue ◽  
Potential Benefits

Methotrexate, a structural analogue of folic acid, is one of the most effective and extensively used drugs for treating many kinds of cancer or severe and resistant forms of autoimmune diseases. In this paper, we take an overview of the present state of knowledge with regards to complex mechanisms of methotrexate action and its applications as immunosuppressive drug or chemotherapeutic agent in oncological combination therapy. In addition, the issue of the potential benefits of methotrexate in the development of neurological disorders in Alzheimer’s disease or myasthenia gravis will be discussed.

Clinical and laboratory features of neuromyelitis optica with oligoclonal IgG bands

2007 ◽  
Vol 13 (3) ◽  
pp. 332-335 ◽  
Author(s):  
M. Nakamura ◽  
I. Nakashima ◽  
S. Sato ◽  
I. Miyazawa ◽  
K. Fujihara ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Autoimmune Diseases ◽  
Myasthenia Gravis ◽  
Neuromyelitis Optica ◽  
Disease Duration ◽  
Sicca Syndrome ◽  
Common Features ◽  
Laboratory Features ◽  
Oligoclonal Igg ◽  
Oligoclonal Igg Bands

Of 23 neuromyelitis optica (NMO) cases, we found two cases with oligoclonal IgG bands (OBs). Both patients were positive for NMO-IgG. Their common features were long disease duration and co-existing autoimmune diseases (myasthenia gravis and sicca syndrome). Although OBs are mostly negative in NMO, which distinguishes it from multiple sclerosis (MS), they can be positive by long-standing autoimmunity, which may not be directly related to NMO. Multiple Sclerosis 2007; 13: 332-335. http://msj.sagepub.com

Myasthenia Gravis: Prototype of the Antireceptor Autoimmune Diseases

1990 ◽  
pp. 175-200 ◽  
Author(s):  
Simone Schönbeck ◽  
Susanne Chrestel ◽  
Reinhard Hohlfeld
Keyword(s):  
Autoimmune Diseases ◽  
Myasthenia Gravis

Associated autoimmune diseases following complete remission of myasthenia gravis

2009 ◽  
Vol 92 (6) ◽  
pp. 503-504 ◽  
Author(s):  
Ken Ikeda ◽  
Mayumi Abe ◽  
Yoh Araki ◽  
Masao Kinoshita ◽  
P.B. Christensen
Keyword(s):  
Complete Remission ◽  
Autoimmune Diseases ◽  
Myasthenia Gravis

Thymectomy: A potential therapeutic method for autoimmune diseases besides myasthenia gravis

2008 ◽  
Vol 70 (5) ◽  
pp. 1072-1073
Author(s):  
Wei Guo ◽  
Yun-Ping Zhao ◽  
Yao-Guang Jiang ◽  
Shi-Zhi Fan ◽  
Ru-Wen Wang ◽  
...  
Keyword(s):  
Autoimmune Diseases ◽  
Myasthenia Gravis ◽  
Therapeutic Method

Clinical Characteristics and Prognosis of Myasthenia Gravis with Other Autoimmune Diseases

1986 ◽  
Vol 41 (2) ◽  
pp. 189-192 ◽  
Author(s):  
Yasumasa Monden ◽  
Tadashi Uyama ◽  
Kazuya Nakahara ◽  
Yoshitaka Fujii ◽  
Jumpei Hashimoto ◽  
...  
Keyword(s):  
Autoimmune Diseases ◽  
Myasthenia Gravis ◽  
Clinical Characteristics

scholarly journals Thymic tumours and their special features

2021 ◽  
Vol 30 (162) ◽  
pp. 200394
Author(s):  
Clémence Basse ◽  
Nicolas Girard
Keyword(s):  
Autoimmune Diseases ◽  
Myasthenia Gravis ◽  
Management Strategies ◽  
Differential Diagnoses ◽  
Pathological Review ◽  
Treatment Sequencing ◽  
Thoracic Malignancies

Thymic tumours are rare thoracic malignancies, that may be aggressive and difficult to treat. The pillars of the management include pathological review, consideration of differential diagnoses, staging and multidisciplinary discussion. Assessment of resectability is key to drive the treatment sequencing. Association with autoimmune diseases, especially myasthenia gravis, is observed, which impacts the oncological management. Networks are being built at the national and international levels. This article provides an overview of the most recent findings in the diagnosis, staging, histology, and management strategies of thymic tumours.

Sign in / Sign up

Export Citation Format

Share Document